Chemicals & Advanced Materials Global On demand · 24-48h

Global Adhesive Liquid Embolic Materials Market Strategic Research Report

Global Adhesive Liquid Embolic Materials Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Adhesive Liquid Embolic Materials Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Cyanoacrylates, GLUBRAN-2 Glue

By Application: Neurovascular Interventional Treatment, Tumor Interventional Treatment, Other

Key Players: GE, Johnson & Johnson, Terumo Corporation, Sexis Biotech, Instylla, Zhuhai Shenping Medical, Medtronic, Penumbra, Guerbet

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 99 pages

Vista general

Scope of the Report

Adhesive liquid embolic material is a liquid preparation that can quickly polymerize, precipitate and firmly adhere to the blood vessel wall in the blood vessel, thereby achieving the purpose of embolizing the blood vessel, isolating the blood or embolizing the diseased blood vessel. Its main characteristics are good adhesion and rapid polymerization, which can form stable emboli in the blood vessel and effectively block blood flow. The main components of adhesive liquid embolic material are usually cyanoacrylate compounds such as α-butyl cyanoacrylate (NBCA). When these compounds come into contact with anions in the blood, they will quickly undergo polymerization to form solid emboli. In addition, in order to increase the development effect of the material, sometimes an appropriate amount of developer such as tantalum powder is added to the material. Adhesive liquid embolic material is mainly used in the clinic to treat various vascular diseases, such as cerebral arteriovenous malformations, aneurysms, etc. Through embolization therapy, the blood supply of the diseased blood vessel can be blocked, the risk of bleeding can be reduced, and the patient's symptoms and quality of life can be improved. At the same time, the material can also be used in other fields that require embolization therapy, such as tumor embolism, vascular rupture, etc.

Global key Adhesive Liquid Embolic Materials players cover GE, Johnson & Johnson, Terumo Corporation, Sexis Biotech, Instylla, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Adhesive Liquid Embolic Materials market?

What factors are driving Adhesive Liquid Embolic Materials market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Adhesive Liquid Embolic Materials market opportunities vary by end market size?

How does Adhesive Liquid Embolic Materials break out by Type, by Application?

This report presents a comprehensive overview of the global Adhesive Liquid Embolic Materials market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Cyanoacrylates
  • GLUBRAN-2 Glue

Segment by Application

  • Neurovascular Interventional Treatment
  • Tumor Interventional Treatment
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Adhesive Liquid Embolic Materials market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Neurovascular Interventional Treatment, Tumor Interventional Treatment, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
CyanoacrylatesGLUBRAN-2 Glue
By Application
Neurovascular Interventional TreatmentTumor Interventional TreatmentOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Cyanoacrylates
  • 3.1.3 GLUBRAN-2 Glue
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Neurovascular Interventional Treatment
  • 4.1.3 Tumor Interventional Treatment
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 GE
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Johnson & Johnson
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Terumo Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sexis Biotech
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Instylla
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Zhuhai Shenping Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Medtronic
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Penumbra
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Guerbet
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is Adhesive Liquid Embolic Materials?
Adhesive liquid embolic material is a liquid preparation that can quickly polymerize, precipitate and firmly adhere to the blood vessel wall in the blood vessel, thereby achieving the purpose of embolizing the blood vessel, isolating the blood or embolizing the diseased blood vessel. Its main characteristics are good adhesion and rapid polymerization, which can form stable emboli in the blood vessel and effectively block blood flow.
How is the Adhesive Liquid Embolic Materials market segmented by type?
By type, the market is segmented into Cyanoacrylates and GLUBRAN-2 Glue.
What are the key applications of Adhesive Liquid Embolic Materials?
Key applications covered include Neurovascular Interventional Treatment, Tumor Interventional Treatment and Other.
Which companies are profiled in the Adhesive Liquid Embolic Materials market report?
Key players profiled include GE, Johnson & Johnson, Terumo Corporation, Sexis Biotech, Instylla, Zhuhai Shenping Medical, Medtronic and Penumbra, among 9 companies covered in total.
What geographies does the Adhesive Liquid Embolic Materials market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Adhesive Liquid Embolic Materials?
What factors are driving Adhesive Liquid Embolic Materials market growth, globally and by region?
Who should buy the Adhesive Liquid Embolic Materials market report?
The report is intended for manufacturers and solution providers, distributors and end users in Neurovascular Interventional Treatment, Tumor Interventional Treatment and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Adhesive Liquid Embolic Materials market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.